Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Lafrance James T, Executive. Insider active across 1 company, notably Aspira Women's Health Inc.. In total, 3 disclosures have been published. Activity tracked since 6 May 2021. The latest transaction was disclosed on 31 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
James T. Lafrance is a Director at Aspira Women's Health Inc. In this role, he contributes to the governance of the company and strategic decision-making. Lafrance brings valuable expertise in the healthcare sector, helping Aspira achieve its goals.